# FDA recall Z-0662-2024

> **Baxter Healthcare Corporation** · Class II · device recall initiated 2023-12-06.

## Product

Baxter FloSeal Hemostatic Matrix RECOTHROM, Product Codes:   a) ADS202105, 5mL-6 PK US  b) ADS202110, 10mL US

## Reason for recall

Cardiovascular Surgery marketing brochure (US-AS46-220001) that was distributed for the products listed below contains inaccurate content that does not align with some of the products Instructions for Use (IFU) or Prescribing Information (PI).

## Distribution

US Nationwide distribution.

## Key facts

- **Recall number:** Z-0662-2024
- **Recalling firm:** Baxter Healthcare Corporation
- **Classification:** Class II
- **Product type:** device
- **Status:** Ongoing
- **Initiation date:** 2023-12-06
- **Report date:** 2024-01-17

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Deerfield, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0662-2024

## Citation

> AI Analytics. FDA recall Z-0662-2024. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/Z-0662-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*